Spectral Medical Inc
TSX:EDT

Watchlist Manager
Spectral Medical Inc Logo
Spectral Medical Inc
TSX:EDT
Watchlist
Price: 1.28 CAD -2.29% Market Closed
Market Cap: 370.1m CAD

Wall Street
Price Targets

EDT Price Targets Summary
Spectral Medical Inc

Wall Street analysts forecast EDT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EDT is 3.16 CAD with a low forecast of 2.73 CAD and a high forecast of 3.68 CAD.

Lowest
Price Target
2.73 CAD
113% Upside
Average
Price Target
3.16 CAD
147% Upside
Highest
Price Target
3.68 CAD
187% Upside
Spectral Medical Inc Competitors:
Price Targets
EXEL
Exelixis Inc
10% Upside
KURN
Kuros Biosciences AG
16% Upside
IONS
Ionis Pharmaceuticals Inc
8% Upside
COV
Covalon Technologies Ltd
94% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
59% Upside
ACAD
ACADIA Pharmaceuticals Inc
11% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
48% Upside
GYRE
Gyre Therapeutics Inc
120% Upside

Revenue
Forecast

Revenue Estimate
Spectral Medical Inc

For the last 13 years the compound annual growth rate for Spectral Medical Inc's revenue is 0%. The projected CAGR for the next 3 years is 78%.

0%
Past Growth
78%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Spectral Medical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat

Net Income
Forecast

Net Income Estimate
Spectral Medical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-25%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EDT's stock price target?
Price Target
3.16 CAD

According to Wall Street analysts, the average 1-year price target for EDT is 3.16 CAD with a low forecast of 2.73 CAD and a high forecast of 3.68 CAD.

What is Spectral Medical Inc's Revenue forecast?
Projected CAGR
78%

For the last 13 years the compound annual growth rate for Spectral Medical Inc's revenue is 0%. The projected CAGR for the next 3 years is 78%.

Back to Top